Axxess Pharma, Inc. AXXE
–
We’re touching base with AXXE again this morning, as the company has made some exciting announcements over the past couple of days including the acquisition of assets previously belonging to Revive Bioscience Inc., a Canadian OTC healthcare company, a move that widens AXXE’s catalog of pharma products significantly. Even more exciting is the fact that Revive held the rights to several branded OTC products endorsed by professional athletes in many major American sports including the NFL, NHL, and more.
–
Additionally, in a PR from yesterday we learned that AXXE has also made an addition to an already strong management team, with the appointment of Robert Tallack, who will serve as VP of Sales and Marketing. You can read more in depth about both developments by clicking through the press links below, but first, we’re going to take a look at how the AXXE chart is faring via the following video:
Be sure to check out the Exclusive Interview our sister site, Stock Traders Talk, conducted with AXXE President Dr. Daniel Bagi last week:
AXXE Interview
You can also take a look at our initial report on the company:
AXXE Report
- Axxess Pharma Inc. Acquires Existing Revenues, Patents, Formulations and NFL, NHL, UFC Athlete Endorsed Products From Leading Canadian OTC Healthcare Company Marketwired (Tue, Sep 17)
- Axxess Pharma Inc. Bolsters Management With Key Addition to Sales & Marketing Team Marketwired (Mon, Sep 16)
- Axxess Pharma Inc. President, Daniel Bagi, M.D. Provides Exclusive Interview on StockTradersTalk.com Marketwired (Thu, Sep 12)
- More info at: www.axxesspharmainc.com
Extended Watchlist:
FREE, DRYS, GOGO, RAD